pubmed:abstractText |
Discoid lupus erythematosus (DLE) is commonly treated with topical agents, the most important of which are glucocorticosteroids. However, prolonged use of these agents, especially on sensitive areas such as the face, may result in side-effects (e.g. atrophy and telangiectases) by altering collagen synthesis. Therefore, alternative treatments are needed for these patients.
|
pubmed:affiliation |
Skin Research Centre, Shahid Beheshti University, M.C., Shohada-e Tajrish Hospital, Tehran, Iran. bbarikbin@gmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|